CryoLife Inc. (NYSE:CRY) said today that it named Pat Mackin, the former president of Medtronic‘s (NYSE:MDT) cardiac rhythm disease management division, to be its new president & CEO.
Mackin is slated to take over the corner office at Atlanta-based CryoLife Sept. 2, according to a press release, with current president & CEO Steven Anderson keeping that role until then. Anderson will then become chairman, according to the release.
"We are excited to have Pat Mackin join us as our chief executive officer and president. We believe he is an ideal leader for CryoLife given his strong background in cardiac and vascular medical devices and broad international sales and marketing experience. In addition, Pat’s accomplishments, professionalism and commitment to excellence complement the culture, mission and values of CryoLife perfectly. I am confident that Pat will bring significant value as we continue to execute on our growth strategy and, personally, I am greatly looking forward to working with him," Anderson said in prepared remarks.
"In CryoLife, I found the right combination of culture, innovation and a shared long-term vision. The company is in a strong position to continue building on its leadership in cardiac and vascular surgery with its existing products, new product pipeline and continued business development activity. I look forward to contributing to the growth strategy and I am excited by the opportunity to become part of a great team and feel privileged to join the CryoLife family as we work together to deliver great solutions to the marketplace," Mackin added.
Mackin’s résumé includes stints at Genzyme Corp. (NSDQ:GENZ) and Deknatel/Snowden-Pencer, according to the release.